Related Experiment Video
Updated: Jun 3, 2026
03:42
Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess
Published on: March 15, 2024
Minimally invasive retroperitoneal pancreatic necrosectomy
Hairul A Ahmad1, Inian Samarasam, Jeffrey M Hamdorf
1School of Surgery, The University of Western Australia, Perth, W.A., Australia. hairulahmad@gmail.com
Summary
Minimally invasive pancreatic necrosectomy (MIPN) offers good outcomes for severe acute pancreatitis. This case series shows acceptable morbidity and mortality, with minimal intensive care unit (ICU) dependency, though multiple procedures may be necessary.
Area of Science:
- Gastroenterology
- Surgical Innovation
Background:
- Severe acute pancreatitis necessitates effective treatment strategies.
- Minimally invasive pancreatic necrosectomy (MIPN) is an evolving surgical approach.
- This study focuses on a single surgeon's experience with retroperitoneal MIPN.
Purpose of the Study:
- To evaluate the outcomes of retroperitoneal minimally invasive pancreatic necrosectomy (MIPN).
- To assess the safety, efficacy, and complication rates of MIPN.
- To report on the long-term results of MIPN in patients with severe acute pancreatitis.
Main Methods:
- A case series of 32 patients undergoing retroperitoneal MIPN from 2006 to 2008.
- Data collected prospectively in a computerized database.
- Analysis of procedure count, complications, and outcomes.
Main Results:
- 93 MIPN procedures were performed on 32 patients with severe acute pancreatitis.
- Median of 3 MIPN procedures per patient.
- 15 complications occurred, including bleeding, bowel fistulae, and thromboembolic events. Mortality was 13% (4 patients).
- 4 patients developed pseudocysts requiring intervention within 2 years.
Conclusions:
- Retroperitoneal MIPN can be performed with acceptable morbidity and mortality.
- Good end results were achieved with MIPN.
- Multiple MIPN procedures may be required for satisfactory necrosis eradication.